Getting COVID Raises Odds for Guillain-Barre Syndrome, Vaccination Lowers Risk
COVID infection can raise the risk of a rare immune system attack on the body's nerves -- but vaccination might protect against it, a large new study suggests.
Stay updated with breaking news from Dennis Bourdette. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COVID infection can raise the risk of a rare immune system attack on the body's nerves -- but vaccination might protect against it, a large new study suggests.
Washington, Oct 18 (Prensa Latina) A new study from Israel ties Covid-19 infection to an increased risk of a diagnosis of Guillain-Barre syndrome (GBS) within 6 weeks, while mRNA vaccination was linked to a decreased risk of the rare but serious autoimmune disease.
But vaccination seems to decrease the risk of developing the rare condition
Evidence review reveals little, if any, clinical benefit to drug that costs Medicare hundreds of millions of dollars annually An extremely expensive
Findings support FDA warning for recombinant zoster vaccine